Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Team at Warner-Lambert presents new MMP inhibitors

May 25, 1998

New agents for schizophrenia from Meiji Seika

May 25, 1998

Thienopyridines for impotence, heart failure in development at Merck KGaA

May 22, 1998

Sankyo prepares neuraminic acid compounds useful for preventing the flu

May 22, 1998

Fibrinogen receptor antagonists claimed by DuPont Merck

May 22, 1998

New antioxidants from Warner-Lambert

May 22, 1998

Selective dopamine D3 receptor ligands developed at Neurogen

May 22, 1998

Cytokine-suppressive antiinflammatory drugs from SKB

May 22, 1998

New penems in development at Menarini and Lusofarmaco

May 21, 1998

Phosphonate nucleotides with antiviral/antitumor activity from Mitsubishi

May 21, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...